Beraprost-314d Added-on to Tyvaso® (BEAT)

Clinical trial NCT01908699 · COMPLETED

Trial details

NCT number: NCT01908699
Sponsor: Lung Biotechnology PBC
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Pulmonary Arterial Hypertension

Start date: 2013-05-31
Primary completion: 2019-02-19
Enrollment: 273

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.